Invesco Ltd. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 158 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$279,922
-48.1%
120,138
-0.5%
0.00%
Q1 2024$539,454
+64.8%
120,683
+18.3%
0.00%
Q4 2023$327,343
+10.4%
101,976
+9.1%
0.00%
Q3 2023$296,433
-35.4%
93,512
+1.3%
0.00%
Q2 2023$458,582
-2.3%
92,270
-2.9%
0.00%
Q1 2023$469,340
-16.9%
95,008
+5.8%
0.00%
Q4 2022$564,887
-42.0%
89,807
-0.4%
0.00%
Q3 2022$974,000
-85.7%
90,191
-84.9%
0.00%
-100.0%
Q2 2022$6,820,000
+808.1%
598,165
+624.6%
0.00%
Q1 2022$751,000
+35.1%
82,553
+121.9%
0.00%
Q4 2021$556,000
-38.4%
37,201
+6.0%
0.00%
Q3 2021$902,000
-12.3%
35,110
-10.9%
0.00%
Q2 2021$1,028,000
+37.6%
39,411
+86.1%
0.00%
Q1 2021$747,000
+45.6%
21,175
+4.2%
0.00%
Q4 2020$513,000
+9.6%
20,327
+63.5%
0.00%
Q3 2020$468,000
-13.2%
12,431
-1.4%
0.00%
Q2 2020$539,000
+101.9%
12,607
-8.2%
0.00%
Q1 2020$267,00013,7300.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$4,189,7204.58%
SUPERSTRING CAPITAL MANAGEMENT LP 689,912$1,607,4952.03%
Lynx1 Capital Management LP 2,228,295$5,191,9271.87%
Wildcat Capital Management, LLC 2,920,787$6,805,4341.66%
TPG GP A, LLC 18,716,306$43,608,9931.00%
Boxer Capital, LLC 3,850,000$8,970,5000.47%
Vestal Point Capital, LP 2,200,000$5,126,0000.38%
DAFNA Capital Management LLC 605,100$1,409,8830.34%
Frazier Life Sciences Management, L.P. 2,867,750$6,681,8580.31%
Coastal Bridge Advisors, LLC 406,847$947,9540.24%
View complete list of ALLOGENE THERAPEUTICS INC shareholders